Warning: fopen(/home/virtual/pediatrics/journal/upload/ip_log/ip_log_2025-05.txt) [function.fopen]: failed to open stream: Permission denied in /home/virtual/pediatrics/journal/ip_info/view_data.php on line 93

Warning: fwrite(): supplied argument is not a valid stream resource in /home/virtual/pediatrics/journal/ip_info/view_data.php on line 94
Anxiety disorders presenting as gastrointestinal symptoms in children – a scoping review

Anxiety disorders presenting as gastrointestinal symptoms in children – a scoping review

Article information

Clin Exp Pediatr. 2025;68(5):344-351
Publication date (electronic) : 2025 January 13
doi : https://doi.org/10.3345/cep.2024.01732
1Swansea University, Swansea, UK
2Morriston Hospital, Swansea, UK
Corresponding author: Anjali Kumar, BSc. Swansea University, Singleton Park, Swansea, SA2 8PP, UK Email: 2001073@swansea.ac.uk
Received 2024 November 22; Revised 2025 January 3; Accepted 2025 January 8.

Abstract

Functional gastrointestinal disorders (FGID) and their association with anxiety disorders in children significantly impact a child’s functioning and treatment response. This study aimed to scope the evidence of anxiety disorders manifesting as FGID in children up to 16 years old. A comprehensive search strategy was conducted on Embase (1974-2024), MEDLINE (via EBSCOHost 1946-2024), and APA PsycINFO (via EBSCOHost 1967-2024). Articles were retrieved, screened, and assessed for bias using the GRADE system. Our initial search yielded 1984 articles. After screening titles and abstracts, 53 articles remained. Full-text screening further narrowed this to 4 eligible studies. The first study found that anxiety indirectly influenced abdominal pain severity in children with irritable bowel syndrome. The second study reported an association between anxiety and abdominal pain but found that anxiety might not predict abdominal pain in later childhood. The third study suggested FGID could be a risk factor for anxiety, with higher anxiety rates in children with FGID compared to those without. The fourth study found no significant difference in pain intensity between children with functional abdominal pain disorders (FAPD) alone and those with FAPD and anxiety. The reviewed studies indicate a relationship between anxiety and FGID but lack clarity on directionality or causation. The limited number of studies calls for more research, including case-control studies with large sample sizes and longitudinal cohort studies to investigate the incidence and causation.

Key message

A positive bidirectional relationship between gastrointestinal disorders and anxiety, but with no clear aetiology, was identified. Factors such as somatisation and pain catastrophising resulted in poorer pain-related outcomes in children. Further studies are required to understand this relationship in order to have targeted treatments and ensure better long term outcomes.

Graphical abstract

Introduction

Mental disorders are a leading cause of disability, with approximately 10%–20% of children and adolescents affected globally [1]. A national survey conducted in 2022 reported that 18% of children aged 7–16 years in the United Kingdom had a mental disorder [2].

Academic performance can be significantly impacted by anxiety, with children less likely to engage in school, have poorer academic performance, or leave schooling earlier compared to their peers [3]. It can also harm relationships with their peers [1]. Major global disasters, such as the coronavirus disease 2019 pandemic, have further isolated children due to school closures, quarantine orders, increased family stress, and decreased peer interactions [4]. In addition, children with anxiety disorders are at a greater risk of a range of future mental disorders, including eating disorders [3]. Early recognition of anxiety disorders is essential for improving long-term health outcomes in the pediatric population.

The International Classification of Diseases 11th Revision defines anxiety and fear-related characteristics “by excessive fear and anxiety-related behavioural disturbances, with symptoms that are severe enough to result in significant distress or significant impairment in personal, family, social, educational, occupational, or other important areas of functioning.” [5] Generalised anxiety disorder (GAD) is “manifested by either general apprehension or excessive worry focused on multiple everyday events, most often concerning family, health, finances, and school or work, together with additional symptoms such as muscular tension or motor restlessness, sympathetic autonomic overactivity, subjective experience of nervousness, difficulty maintaining concentration, irritability, or sleep disturbance.” [5]

In 1958, Apley and Naish first defined children with medically unexplained abdominal pain as being "timid, nervous, anxious, or overconscientious; the type of children in whom emotional disturbance would be expected to develop." [6] The gastrointestinal tract (GIT) and the brain are interconnected via the gut-brain axis, playing a role in appetite, satiety, and enteroendocrine signalling [7]. The pathogenesis of functional GIT disorders (FGID) and irritable bowel syndrome (IBS) are not yet clearly understood. However, the role of the gut-brain axis has been at the forefront due to the association of high prevalence of depression and anxiety alongside these FGIDs [7]. Particularly in pediatric settings, youths with GIT symptoms, such as nausea, constipation, diarrhoea, abdominal pain, urge incontinence, satiety, and bloating, are more likely to develop anxiety disorders than those without GIT symptoms [8].

It may be difficult to assess whether anxiety manifests as a result of GIT issues or if anxiety causes GIT disturbances. For instance, children with constipation may be anxious and fearful of a painful bowel movement and could avoid further bowel movements, thus exacerbating their symptoms of pain associated with constipation [6]. There has not been enough information to understand the complexity of possible bidirectionality of the gut-anxiety relationship. Unfortunately, epidemiological studies have been hampered due to the lack of appropriate diagnostic criteria for anxiety disorders in GIT conditions [9]. Furthermore, the complexities involved with the relationship between anxiety and FGIDs in the pediatric population and the paucity of clinical guidelines, makes it clinically difficult in regards to the management.

Therefore, this scoping review aims to review the evidence of anxiety disorders manifesting as GIT symptoms in children, particularly to look at the gaps in research, the prevalence, and clinical features.

Methods

1. Search strategy

Comprehensive search strategies were conducted on several databases on January 29 2024:

• Embase (1974–2024)

• MEDLINE (via EBSCOHost 1946–2024)

• APA PsycINFO (via EBSCOHost 1967–2024) The specific search strategies are displayed in Supplementary material 1.

2. Inclusion and exclusion criteria

Participants of both sexes under the age of 16 with either a clinical diagnosis of a functional gut disorder or anxiety were included. Clinical manifestations of anxiety or gastrointestinal symptoms needed to be included in the investigation. Children with diagnoses of conditions such as inflammatory bowel disease (IBD), coeliac disease, or other malignancies were excluded to minimise confounding factors. The use of cognitive behavioural therapy (CBT), hypnotherapy, and antidepressants in the treatment of GIT manifestations of anxiety were also excluded. Only papers from the last 10 years were included.

Restrictions to the study design included case studies, pilot studies, or methodological studies. All studies that were not written in English or not peer-reviewed were excluded.

3. Data extraction

The screening process is summarised by the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-analyses), which is shown in Fig. 1. The final selected papers are summarised in Table 1. The final data extrapolation includes key information such as author, publication date, study design, study population, and key findings.

Fig. 1.

PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-analyses) flowchart depicting the inclusion and exclusion process to yield the final studies for data extraction.

Summary of papers from final data extraction

4. Quality assessment

The 5 GRADE considerations approach was used to assess the overall quality of evidence. The factors considered include risk of bias, consistency of effect, imprecision, indirectness and publication bias.

Results

1. Search results

The search yielded 1984 citations, and 53 were selected for full-text assessment. Of the selected, 49 were excluded for the following reasons: wrong outcome (studies without a focus or subfocus of anxiety and FGIDs) [10-24], wrong patient population (patients over the age of 16 years or with diagnoses of IBD, coeliac disease, or malignancy) [25-44], wrong study design (case studies, pilot studies, or methodological studies) [45-49], wrong intervention (use of psychological therapies) [50-56] or not written in English [57,58]. Finally, 4 papers were included for final data extraction [59-62].

2. Role of anxiety in influencing abdominal pain severity

Two studies found the presence of anxiety and the influence they had on the severity of abdominal pain.

One study that looked at children with IBS found that somatisation and anxiety were significant mediators in the relationship between anxiety and IBS abdominal pain severity [62]. Furthermore, anxiety had a significant role in predicting IBS abdominal pain severity. The authors suggest that the effects of anxiety on IBS outcomes, such as pain, may be indirect through various mediating factors, such as somatisation [62]. The authors also suggested that psychological treatments such as CBT may be beneficial in reducing symptomology in children with IBS.

The second study found that children with functional abdominal pain disorders (FAPD) who reported anxiety on their proposed SCARED (Screen for Anxiety and Related Disorders) screening tool were more likely to meet the criteria of GAD (P<0.001) and social anxiety (P<0.001) [59]. These children were also likely to report significantly higher pain-related disability (P=0.007) compared to children with only FAPD [59]. However, when the study accounted for age and sex, there was no statistical difference between the groups for levels of pain catastrophising (P=0.065) and pain intensity (P=0.367) [59].

3. The relationship between anxiety and GIT conditions

Two studies found a positive association between the presence of anxiety and GIT symptoms, such as abdominal pain.

One study found a positive association between psychological symptoms, including anxiety and nervousness, and abdominal pain [61]. While the study showed a positive association between psychological symptoms and abdominal pain, the authors were unable to predict if psychological symptoms would predict the presence of abdominal pain later on in adolescence [61].

The second study found that FAPD may be a risk factor for internalising disorders, such as anxiety [60]. Furthermore, this risk increases if the child fulfils the Rome-III criteria and may cause greater abdominal pain severity [60]. However, similar to the other studies, the authors were unable to determine if abdominal pain symptoms were a direct consequence of anxiety [60].

The findings from these 4 studies have been summaried in Fig. 2 and Table 1.

Fig. 2.

Illustrative summary of the four papers included in the final data extraction [59-62]. FGID, functional gastrointestinal disorders.

Discussion

This scoping review identified a bidirectional relationship between anxiety and GIT disorders. However, it did not confirm whether there is a direct causal relationship or if the 2 share a common aetiology. The study was limited to selecting studies that primarily investigated GIT symptoms causing anxiety, with only 1 study reporting anxiety as the primary condition [61]. This limitation may be due to the fact that while anxiety and depression are common in the pediatric population, they often go undiagnosed and untreated [63]. As a result, their potential role in exacerbating GIT disorders may be underexplored.

Furthermore, abdominal pain can be a vague symptom of anxiety and may not always represent a manifestation of FAPD. Clinically, this is particularly challenging, as children often struggle to articulate or localise their abdominal pain, making it difficult to determine whether it stems from anxiety or GIT disorders.

Many of the current screening tools for FGID do not distinguish between subclinical or clinical anxiety, and are often based on the child or their family’s perception of anxiety. When children present with abdominal pain or other related symptoms, distress and worry would be present. However, whether these should be considered pathological or diagnosed as anxiety may not be beneficial when determining the best intervention for these patients. Furthermore, there are no validated measures of gastrointestinal-specific anxiety or gastrointestinal avoidance for children with FAPDs [60]. These patients, who avoid situations that may stimulate their GIT symptoms, may have a transient benefit in improving their overall symptoms, but are not exposed enough for them to develop appropriate coping strategies. Therefore, therapies such as exposure-based CBT may be beneficial to these patients if they were able to be identified early enough [60].

In addition, many of these studies simplify anxiety under general psychological conditions, which may include sleep disturbances and depression. It may be difficult to isolate such psychological conditions in these studies, as they all may be related and influenced by the other. For instance, if a child is receiving significantly less sleep due to their GIT symptoms, they are more likely to be at a heightened state of emotional distress, and more susceptible to being anxious [64].

Previous research investigating the pathophysiology of conditions such as IBS has identified visceral hypersensitivity— an increased sensitivity to stimuli in the GIT— as a common feature [36]. However, the origins of this hypersensitivity remain unclear. It is uncertain whether it is mediated by the local gastrointestinal nervous system or by central modulators from the brain [36]. Pain receptors in the abdomen respond to mechanical and chemical stimuli [63], but pain perception is a complex process involving visceral sensitivity and psychological factors [65]. Studies have noted that psychosocial factors, such as anxiety and significant life events—including sexual, emotional, or physical abuse—may influence the manifestation of IBS [66].

It may also be beneficial to have population studies that look at this interaction between the brain and the GIT from childhood to adulthood [64]. One Swedish prospective longitudinal birth cohort study (n=3,391) found that psychological distress at 16 years of age was associated with new onset IBS at 24 years (odds ration [OR], 1.6; 95% confidence interval [CI], 1.2–2.3) [64]. In addition, having any abdominal pain-related disorder at 16 years was associated with new onset psychological distress at 24 years (OR, 1.7; 95% CI, 1.2–2.5) [64].

If conditions such as IBS and FAPD are to be understood through a biopsychosocial framework (Fig. 3), a comprehensive and targeted approach may be necessary to provide holistic treatment for affected children. A multipronged strategy that addresses these disorders' physical and psychological aspects could yield more effective therapeutic outcomes.

Fig. 3.

Biopsychosocial framework which illustrates the 3 domains (biological, psychological, and social) and how they all interact to influence health outcomes.

Additionally, due to the limited number of studies that met the inclusion criteria, it may be necessary to explore further the roles of psychotherapy and psychopharmacology in treating GIT conditions. Such an investigation could indirectly help clarify the relationship between anxiety and GIT symptoms.

Within pediatric emergency departments, 45% of patients meet the criteria for a diagnosis of a mental disorder [65]. Given the prevalence of mental disorders in this population, more refined diagnostic tools are needed to improve long-term outcomes. Studies examining the relationship between chronic GIT disorders and anxiety have shown that early intervention in mental disorders improves adherence to therapy and leads to better clinical outcomes [64]. Some studies also found that participants with abdominal pain were more likely to experience health anxiety [43], suggesting that recurrent abdominal pain may be a somatic manifestation of emotional distress [34].

Animal models further support the idea that early-life adversity can increase the risk of both GIT and mental disorders [14]. These models suggest that, like brain plasticity, the pediatric gut microbiome is highly sensitive to environmental factors that can influence its maturation [14]. This raises the possibility that early interventions to mitigate psychological stress could positively impact the gut microbiome and overall GIT health.

Research implications

This review has identified the need to develop more objective screening or diagnostic tools for anxiety and GIT conditions for early intervention. More rigorous, randomised trials with larger sample sizes may be necessary. To identify the causative effect, longitudinal studies which look at separate cohorts with only anxiety disorders and only GIT symptoms with long-term follow-up will be required.

Conclusions

Numerous studies have highlighted a relationship between anxiety FGIDs, yet there remains a significant lack of clarity on the directionality and underlying mechanisms of this association. While it is well-established that individuals with FGIDs often report higher levels of anxiety, it remains unclear whether anxiety acts as a precursor to the development of these disorders or emerges as a consequence of chronic gastrointestinal symptoms. This ambiguity stems from a paucity of rigorous research focused on determining causality, as many existing studies are cross-sectional, limiting their ability to establish temporal relationships.

To gain a clearer understanding of the link between anxiety and FGIDs, further research is urgently needed. In particular, large-scale case-control studies could help identify distinguishing factors between affected and non-affected populations, while longitudinal cohort studies would be instrumental in tracing the development of FGIDs in individuals over time. Such studies would provide valuable insights into whether anxiety precedes the onset of FGIDs or if these disorders independently trigger heightened anxiety. By investigating the incidence and causation, future research could inform more effective treatment approaches that simultaneously address psychological and gastrointestinal symptoms.

Supplementary material

Supplementary material 1 is available at https://doi.org/10.3345/cep.2024.01732.

Supplementary material

Search strategies

cep-2024-01732-Supplementary-Material.pdf

Notes

Conflicts of interest

No potential conflict of interest relevant to this article was reported.

Funding

This study received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

Data availability

The data that support the findings of this study can be provided by the corresponding author upon reasonable request.

Author Contribution

Conceptualization: PV, AK; Data curation: AK; Formal analysis: AK; Methodology: PV, AK; Project administration: PV, AK; Visualization: PV, AK; Writing - original draft: AK; Writing - review & editing: PV, AK

References

1. Barker MM, Beresford B, Fraser LK. Incidence of anxiety and depression in children and young people with life-limiting conditions. Pediatr Res 2023;93:2081–90.
2. Digital N. Mental health of children and young people in England 2022 - wave 3 follow up to the 2017 survey [Internet]. NHS [updated 2022; cited 2024 Mar 12]. Available from: https://digital.nhs.uk/data-and-information/publications/statistical/mental-health-of-children-and-young-people-inengland/2022-follow-up-to-the-2017-survey#data-sets.
3. Rapee RM, Creswell C, Kendall PC, Pine DS, Waters AM. Anxiety disorders in children and adolescents: a summary and overview of the literature. Behav Res Ther 2023;168:104376.
4. Racine N, McArthur BA, Cooke JE, Eirich R, Zhu J, Madigan S. Global prevalence of depressive and anxiety symptoms in children and adolescents during COVID-19: a meta-analysis. JAMA Pediatr 2021;175:1142–50.
5. International Statistical Classification of Diseases and Related Health Problems (11th ed, ICD-11) Geneva (Switzerland): World Health Organization; 2022.
6. Waters AM, Schilpzand E, Bell C, Walker LS, Baber K. Functional gastrointestinal symptoms in children with anxiety disorders. J Abnorm Child Psychol 2013;41:151–63.
7. Söderquist F, Syk M, Just D, Kurbalija Novicic Z, Rasmusson AJ, Hellström PM, et al. A cross-sectional study of gastrointestinal symptoms, depressive symptoms and trait anxiety in young adults. BMC Psychiatry 2020;20:535.
8. Baumel WT, Mills JA, Schroeder HK, Neptune Z, Levine A, Strawn JR. Gastrointestinal symptoms in pediatric patients with anxiety disorders and their relationship to selective serotonin reuptake inhibitor treatment or placebo. Child Psychiatry Hum Dev 2023;Sep. 2. doi: 10.1007/s10578-023-01586-x. [Epub].
9. Thapar N, Benninga MA, Crowell MD, Di Lorenzo C, Mack I, Nurko S, et al. Paediatric functional abdominal pain disorders. Nat Rev Dis Primers 2020;6:89.
10. Ataee P, Badiee H, Mohammadzadeh S, Moradveisi B, Roshani D, Nasiri R, et al. The relationship between obsessive-compulsive disorders and childhood chronic functional constipation. Acta Med Iran 2021;59:499–503.
11. Chumpitazi BP, Weidler EM, Lu DY, Tsai CM, Shulman RJ. Self-perceived food intolerances are common and associated with clinical severity in childhood irritable bowel syndrome. J Acad Nutr Diet 2016;116:1458–64.
12. Czyzewski DI, Self MM, Williams AE, Weidler EM, Blatz AM, Shulman RJ. Maintenance of pain in children with functional abdominal pain. J Pediatr Gastroenterol Nutr 2016;62:393–8.
13. Gulewitsch MD, Weimer K, Enck P, Schwille-Kiuntke J, Hautzinger M, Schlarb AA. Stress reactivity in childhood functional abdominal pain or irritable bowel syndrome. Eur J Pain 2017;21:166–77.
14. Callaghan BL, Fields A, Gee DG, Gabard-Durnam L, Caldera C, Humphreys KL, et al. Mind and gut: associations between mood and gastrointestinal distress in children exposed to adversity. Dev Psychopathol 2020;32:309–28.
15. Liyanarachchi H, Rajindrajith S, Kuruppu C, Chathurangana P, Ranawaka R, Devanarayana NM, et al. Association between childhood constipation and exposure to stressful life events: a systematic review. Neurogastroenterol Motil 2022;34e14231.
16. Low EXS, Mandhari MNKA, Herndon CC, Loo EXL, Tham EH, Siah KTH. Parental, perinatal, and childhood risk factors for development of irritable bowel syndrome: a systematic review. J Neurogastroenterol Motil 2020;26:437–46.
17. Singh M, Singh V, Schurman JV, Colombo JM, Friesen CA. The relationship between mucosal inflammatory cells, specific symptoms, and psychological functioning in youth with irritable bowel syndrome. Sci Rep 2020;10:11988.
18. Williams AE, Czyzewski DI, Self MM, Shulman RJ. Are child anxiety and somatization associated with pain in pain-related functional gastrointestinal disorders? J Health Psychol 2015;20:369–79.
19. Wong GK, Shulman RJ, Malaty HM, Czyzewski D, Seghers VJ, Thompson D, et al. Relationship of gastrointestinal symptoms and psychosocial distress to gastric retention in children. J Pediatr 2014;165:85–91.e1.
20. Sackl-Pammer P, Özlü-Erkilic Z, Jahn R, Karwautz A, Pollak E, Ohmann S, et al. Somatic complaints in children and adolescents with social anxiety disorder. Neuropsychiatr 2018;32:187–95.
21. Strisciuglio C, Martinelli M, Lu P, Bar Lev MR, Beinvogl B, Benninga MA, et al. Overall impact of coronavirus disease 2019 outbreak in children with functional abdominal pain disorders: results from the first pandemic phase. J Pediatr Gastroenterol Nutr 2021;73:689–94.
22. Stromájer GP, Csima M, Iváncsik R, Varga B, Takács K, Stromájer-Rácz T. Stress and anxiety among high school adolescents: correlations between physiological and psychological indicators in a longitudinal follow-up study. Children (Basel) 2023;10:1548.
23. Varni JW, Bendo CB, Shulman RJ, Self MM, Nurko S, Franciosi JP, et al. Interpretability of the PedsQL™ gastrointestinal symptoms scales and gastrointestinal worry scales in pediatric patients with functional and organic gastrointestinal diseases. J Pediatr Psychol 2015;40:591–601.
24. Yang J, Fox M, Cong Y, Chu H, Zheng X, Long Y, et al. Lactose intolerance in irritable bowel syndrome patients with diarrhoea: the roles of anxiety, activation of the innate mucosal immune system and visceral sensitivity. Aliment Pharmacol Ther 2014;39:302–11.
25. Ayonrinde OT, Sanfilippo FM, O'Sullivan TA, Adams LA, Ayonrinde OA, Robinson M, et al. Bowel patterns, gastrointestinal symptoms, and emotional well-being in adolescents: a cohort study. J Gastroenterol Hepatol 2019;34:1946–54.
26. Baysoy G, Güler-Baysoy N, Kesicioğlu A, Akın D, Dündar T, Pamukçu-Uyan A. Prevalence of irritable bowel syndrome in adolescents in Turkey: effects of gender, lifestyle and psychological factors. Turk J Pediatr 2014;56:604–11.
27. Berens S, Banzhaf P, Baumeister D, Gauss A, Eich W, Schaefert R, et al. Relationship between adverse childhood experiences and illness anxiety in irritable bowel syndrome - The impact of gender. J Psychosom Res 2020;128:109846.
28. Bloom PA, Douglas I, VanTieghem M, Tottenham N, Callaghan B. Using gastrointestinal distress reports to predict youth anxiety risk: implications for mental health literacy and community care. Dev Psychobiol 2021;63e22126.
29. Drukker M, Peters JCH, Vork L, Mujagic Z, Rutten BPF, van Os J, et al. Network approach of mood and functional gastrointestinal symptom dynamics in relation to childhood trauma in patients with irritable bowel syndrome and comorbid panic disorder. J Psychosom Res 2020;139:110261.
30. Simpson CA, Schwartz OS, Eliby D, Butler CA, Huang K, O'Brien-Simpson N, et al. Bugs and Brains, the Gut and Mental Health Study: a mixed-methods study investigating microbiota composition and function in anxiety, depression and irritable bowel syndrome. BMJ Open 2021;11e043221.
31. Sahan HE, Yildirim EA, Soylu A, Tabakci AS, Cakmak S, Erkoc SN. Comparison of functional dyspepsia with organic dyspepsia in terms of attachment patterns. Compr Psychiatry 2018;83:12–8.
32. Stein K, Pearson RM, Stein A, Fazel M. The predictive value of childhood recurrent abdominal pain for adult emotional disorders, and the influence of negative cognitive style. Findings from a cohort study. PLoS One 2017;12e0185643.
33. Rexwinkel R, Bovendeert JFM, Rutten JMTM, Frankenhuis C, Benninga MA, Vlieger AM. Long-term follow-up of individual therapist delivered and standardized hypnotherapy recordings in pediatric irritable bowel syndrome or functional abdominal pain. J Pediatr Gastroenterol Nutr 2022;75:24–9.
34. Ayonrinde OT, Ayonrinde OA, Adams LA, Sanfilippo FM, O' Sullivan TA, Robinson M, et al. The relationship between abdominal pain and emotional wellbeing in children and adolescents in the Raine Study. Sci Rep 2020;10:1646.
35. de Bruijn CMA, Geijtenbeek A, Browne PD, Benninga MA, Vlieger AM. Children with functional gastrointestinal disorders with and without co-existing nausea: a comparison of clinical and psychological characteristics. Neurogastroenterol Motil 2023;35e14591.
36. Colombo JM, Deacy AD, Schurman JV, Friesen CA. Heartburn in children and adolescents in the presence of functional dyspepsia and/or irritable bowel syndrome correlates with the presence of sleep disturbances, anxiety, and depression. Medicine (Baltimore) 2021;100e25426.
37. Cunningham NR, Cohen MB, Farrell MK, Mezoff AG, Lynch-Jordan A, Kashikar-Zuck S. Concordant parent-child reports of anxiety predict impairment in youth with functional abdominal pain. J Pediatr Gastroenterol Nutr 2015;60:312–7.
38. Korterink JJ, Diederen K, Benninga MA, Tabbers MM. Epidemiology of pediatric functional abdominal pain disorders: a meta-analysis. PLoS One 2015;10e0126982.
39. Machnes-Maayan D, Elazar M, Apter A, Zeharia A, Krispin O, Eidlitz-Markus T. Screening for psychiatric comorbidity in children with recurrent headache or recurrent abdominal pain. Pediatr Neurol 2014;50:49–56.
40. Rajindrajith S, Ranathunga N, Jayawickrama N, van Dijk M, Benninga MA, Devanarayana NM. Behavioral and emotional problems in adolescents with constipation and their association with quality of life. PLoS One 2020;15e0239092.
41. Rutten JM, Benninga MA, Vlieger AM. IBS and FAPS in children: a comparison of psychological and clinical characteristics. J Pediatr Gastroenterol Nutr 2014;59:493–9.
42. Santucci NR, Velasco-Benitez CA, Cunningham N, Li J, Fei L, Sun Q, et al. Psychological distress and coping effi cacy in children with disorders of gut-brain interaction. Neurogastroenterol Motil 2024;36e14724.
43. Sangari RS, Hashemi M, Salehi B, Yousefichaijan P, Rafiei M, Rezagholizamenjany M. Anxiety disorders in children with functional constipation: a case-control study. J Compr Pediatr 2022;13e119997.
44. Torabi F, Hashemi M, Zamanian M, Shayganfard M, Yousefichaijan P. The prevalence of social anxiety in children with chronic functional constipation. J Compr Pediatr 2023;14e132384.
45. Cunningham NR, Moorman E, Brown CM, Mallon D, Chundi PK, Mara CA, et al. Integrating psychological screening into medical care for youth with abdominal pain. Pediatrics 2018;142e20172876.
46. Pollard KL, Campbell C, Squires M, Palsson O, van Tilburg MAL. Seasonal association of pediatric functional abdominal pain disorders and anxiety. J Pediatr Gastroenterol Nutr 2018;67:18–22.
47. Newton E, Schosheim A, Patel S, Chitkara DK, van Tilburg MAL. The role of psychological factors in pediatric functional abdominal pain disorders. Neurogastroenterol Motil 2019;31e13538.
48. Rutten JM, Vlieger AM, Frankenhuis C, George EK, Groeneweg M, Norbruis OF, et al. Gut-directed hypnotherapy in children with irritable bowel syndrome or functional abdominal pain (syndrome): a randomized controlled trial on self exercises at home using CD versus individual therapy by qualified therapists. BMC Pediatr 2014;14:140.
49. Tarbell SE, Millar A, Laudenslager M, Palmer C, Fortunato JE. Anxiety and physiological responses to the Trier Social Stress Test for Children in adolescents with cyclic vomiting syndrome. Auton Neurosci 2017;202:79–85.
50. de Bruijn CMA, Rexwinkel R, Gordon M, Benninga M, Tabbers MM. Antidepressants for functional abdominal pain disorders in children and adolescents. Cochrane Database Syst Rev 2021;2:CD008013.
51. Abbott RA, Martin AE, Newlove-Delgado TV, Bethel A, Thompson-Coon J, Whear R, et al. Psychosocial interventions for recurrent abdominal pain in childhood. Cochrane Database Syst Rev 2017;1:CD010971.
52. Gordon M, Sinopoulou V, Tabbers M, Rexwinkel R, de Bruijn C, Dovey T, et al. Psychosocial interventions for the treatment of functional abdominal pain disorders in children: a systematic review and meta-analysis. JAMA Pediatr 2022;176:560–8.
53. Lalouni M, Ljótsson B, Bonnert M, Ssegonja R, Benninga M, Bjureberg J, et al. Clinical and cost effectiveness of online cognitive behavioral therapy in children with functional abdominal pain disorders. Clin Gastroenterol Hepatol 2019;17:2236–44.e11.
54. Lalouni M, Hesser H, Bonnert M, Hedman-Lagerlöf E, Serlachius E, Olén O, et al. Breaking the vicious circle of fear and avoidance in children with abdominal pain: a mediation analysis. J Psychosom Res 2021;140:110287.
55. Roohafza H, Pourmoghaddas Z, Saneian H, Gholamrezaei A. Citalopram for pediatric functional abdominal pain: a randomized, placebo-controlled trial. Neurogastroenterol Motil 2014;26:1642–50.
56. Vasant DH, Hasan SS, Cruickshanks P, Whorwell PJ. Gutfocused hypnotherapy for children and adolescents with irritable bowel syndrome. Frontline Gastroenterol 2020;12:570–7.
57. Banihashem SS, Ghadikolaee AA, Sadeghi A, Rastegar R, Mirzaei M, Saber FY. Lifestyle modification for improving anxiety and depression among patients with irritable bowel syndrome. Gastroenterol Hepatol 2022;76:327–33.
58. Marczyńska P, Kowalkowska K, Kuczyńska R, Czerwionka-Szaflarska M, Krogulska A. [Evaluation of anger expression, school functioning and a level of anxiety in children and adolescents with functional abdominal pain]. Dev Period Med 2016;20:306–14. Polish.
59. Aggarwal Dutta R, Ely SL, Cunningham NR. The Utility of an anxiety screening measure in youth with functional abdominal pain disorders and clinical characteristics associated with presence of anxiety. Clin J Pain 2021;37:616–22.
60. Von Gontard A, Moritz AM, Thome-Granz S, Equit M. Abdominal pain symptoms are associated with anxiety and depression in young children. Acta Paediatr 2015;104:1156–63.
61. Gustafsson ML, Laaksonen C, Salanterä S, Löyttyniemi E, Aromaa M. Associations between daytime sleepiness, psychological symptoms, headache, and abdominal pain in schoolchildren. J Sch Nurs 2019;35:279–86.
62. Hollier JM, van Tilburg MAL, Liu Y, Czyzewski DI, Self MM, Weidler EM, et al. Multiple psychological factors predict abdominal pain severity in children with irritable bowel syndrome. Neurogastroenterol Motil 2019;31e13509.
63. Sjölund J, Kull I, Bergström A, Ljótsson B, Törnblom H, Olén O, et al. Quality of life and bidirectional gut-brain interactions in irritable bowel syndrome from adolescence to adulthood. Clin Gastroenterol Hepatol 2024;22:858–66.e6.
64. Lalouni M, Olén O, Bjureberg J, Bonnert M, Chalder T, Hedman- Lagerlöf E, et al. Validation of child-adapted short scales for measuring gastrointestinal-specific avoidance and anxiety. Acta Paediatr 2022;111:1621–7.
65. Hommel KA, McGraw KL, Ammerman RT, Heubi JE, Hansen M, Dunlap E, et al. Psychosocial functioning in children and adolescents with gastrointestinal complaints and disorders. J Clin Psychol Med Settings 2010;17:159–66.
66. Raichle ME. The restless brain: how intrinsic activity organizes brain function. Philos Trans R Soc Lond B Biol Sci 2015;370:20140172.

Article information Continued

Fig. 1.

PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-analyses) flowchart depicting the inclusion and exclusion process to yield the final studies for data extraction.

Fig. 2.

Illustrative summary of the four papers included in the final data extraction [59-62]. FGID, functional gastrointestinal disorders.

Fig. 3.

Biopsychosocial framework which illustrates the 3 domains (biological, psychological, and social) and how they all interact to influence health outcomes.

Table 1.

Summary of papers from final data extraction

Study Year Study population Participants Methodology Key findings
Aggarwal Dutta et al. [59] 2021 Children and adoles­cents (aged 9–14 yr) with functional abdo­minal pain disorders 93 Participants Semi-structured diagnostic inter­view Participants who reported anxiety on the SCARED, a patient-reported anxiety tool, were more likely to meet the criteria for GAD (P<0.001) and social anxiety (P<0.001). These participants were also reported to have poorer pain-related outcomes.
Von Gontard et al. [60] 2015 Children aged 5–7 yr 952Participants Questionnaire Of the participants, 30.1% of the children reported abdominal pain symptoms. Children without abdominal pain reported lower rates of symptoms of anxiety and depression (7.7%) compared to children with FGID (21.4%). This study was unable to analyse if abdominal pain symptoms are a manifestation of anxiety symptoms or vice versa.
Gustafsson et al. [61] 2019 Children aged 9–15 yr 568Participants Population-based cohort study There was a positive association between the presence of psychological symptoms (anxiety, depression) and abdominal pain (F1=131.0, P<0.0001). Psychological symptoms at the age of 10 did not significantly predict abdominal pain at age 15 (P=0.074).
Hollier et al. [62] 2018 Children aged 7–13 yr with IBS 261 Participants Mediation analysis A multiple mediation analysis illustrated that anxiety predicted IBS abdominal pain severity and had a mediated effect of 0.18 (95% CI, 0.09–0.27). Participants with both somatisation (mediated standardised β, 0.11; 95% CI, 0.05–0.18) and pain catastrophising (mediated standardised β 0.08) impacted the relationship between anxiety and IBS severity. While the study was unable to determine the direct causation, they concluded that further assessment of these psychological factors may be beneficial in treatment of IBS abdominal pain severity.

SCARED, Screen for Anxiety and Related Disorders; GAD, generalised anxiety disorder; FGID, functional gastrointestinal disorder; CI, confidence interval; IBS, irritable bowel syndrome.